Zobrazeno 1 - 10
of 394
pro vyhledávání: '"Mearns, H"'
Autor:
Horsnell, W G C, Vira, A, Kirstein, F, Mearns, H, Hoving, J C, Cutler, A J, Dewals, B, Myburgh, E, Kimberg, M, Arendse, B, White, N, Lopata, A, Burger, P E, Brombacher, F
Publikováno v:
In Mucosal Immunology January 2011 4(1):83-92
Autor:
Lin WY; Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Fordham SE; Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Sunter N; Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Elstob C; Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Rahman T; Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Willmore E; Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Shepherd C; Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Strathdee G; Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Mainou-Fowler T; Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Piddock R; Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Mearns H; Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Barrow T; Faculty of Health Sciences and Wellbeing, University of Sunderland, Sunderland, UK., Houlston RS; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK., Marr H; Department of Haematology, Freeman Hospital, Newcastle upon Tyne, UK., Wallis J; Department of Haematology, Freeman Hospital, Newcastle upon Tyne, UK., Summerfield G; Queen Elizabeth Hospital, Gateshead, UK., Marshall S; City Hospitals Sunderland NHS Trust, Sunderland, UK., Pettitt A; University of Liverpool, Liverpool, UK., Pepper C; Brighton and Sussex Medical School, University of Sussex, Brighton, UK., Fegan C; Institute of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, UK., Forconi F; Cancer Sciences Unit, Cancer Research UK and NIHR Experimental Cancer Medicine Centres, University of Southampton, Southampton, UK., Dyer MJS; The Ernest and Helen Scott Haematological Research Institute, Leicester Cancer Research Centre, University of Leicester, Leicester, UK., Jayne S; The Ernest and Helen Scott Haematological Research Institute, Leicester Cancer Research Centre, University of Leicester, Leicester, UK., Sellors A; The Ernest and Helen Scott Haematological Research Institute, Leicester Cancer Research Centre, University of Leicester, Leicester, UK., Schuh A; University of Oxford, Oxford, UK., Robbe P; University of Oxford, Oxford, UK., Oscier D; Royal Bournemouth Hospital, Bournemouth, UK., Bailey J; Hull University Teaching Hospital NHS Trust, Hull, UK., Rais S; Hull University Teaching Hospital NHS Trust, Hull, UK., Bentley A; Centre for Atherothrombosis and Metabolic Disease, Hull York Medical School, Hull, UK., Cawkwell L; University of Hull, Hull, UK., Evans P; Haematological Malignancy Diagnostic Service Laboratory, St James' Institute of Oncology, Leeds, UK., Hillmen P; Section of Experimental Haematology, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK., Pratt G; University of Birmingham, Birmingham, UK., Allsup DJ; Hull University Teaching Hospital NHS Trust, Hull, UK. hycda1@hyms.ac.uk.; Centre for Atherothrombosis and Metabolic Disease, Hull York Medical School, Hull, UK. hycda1@hyms.ac.uk., Allan JM; Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK. james.allan@newcastle.ac.uk.
Publikováno v:
Nature communications [Nat Commun] 2021 Jan 28; Vol. 12 (1), pp. 665. Date of Electronic Publication: 2021 Jan 28.
Autor:
Mearns H; Vaccines for Africa Initiative, University of Cape Town, Cape Town, South Africa. helen.mearns@gmail.com.; School of Public Health & Family Medicine, University of Cape Town, Cape Town, South Africa. helen.mearns@gmail.com., Otiku PK; Vaccines for Africa Initiative, University of Cape Town, Cape Town, South Africa.; School of Public Health & Family Medicine, University of Cape Town, Cape Town, South Africa., Shelton M; Health Sciences Library, University of Cape Town, Cape Town, South Africa., Kredo T; Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa.; Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, University of Stellenbosch, Cape Town, South Africa., Kagina BM; Vaccines for Africa Initiative, University of Cape Town, Cape Town, South Africa.; School of Public Health & Family Medicine, University of Cape Town, Cape Town, South Africa., Schmidt BM; Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa.
Publikováno v:
Systematic reviews [Syst Rev] 2020 Jul 13; Vol. 9 (1), pp. 156. Date of Electronic Publication: 2020 Jul 13.
Autor:
Wang, Haozhe1 (AUTHOR), Barry, Kristian1 (AUTHOR), Zaini, Aidil1 (AUTHOR), Coakley, Gillian1 (AUTHOR), Moyat, Mati1 (AUTHOR), Daunt, Carmel P.1 (AUTHOR), Wickramasinghe, Lakshanie C.1 (AUTHOR), Azzoni, Rossana1 (AUTHOR), Chatzis, Roxanne1 (AUTHOR), Yumnam, Bibek2 (AUTHOR), Camberis, Mali2 (AUTHOR), Le Gros, Graham2 (AUTHOR), Perdijk, Olaf1 (AUTHOR), Foong, Jaime P. P.3 (AUTHOR), Bornstein, Joel C.3 (AUTHOR), Marsland, Benjamin J.1 (AUTHOR), Harris, Nicola L.1 (AUTHOR) Nicola.Harris@monash.edu
Publikováno v:
PLoS Pathogens. 8/14/2024, Vol. 20 Issue 8, p1-26. 26p.
Autor:
Zaman, Muhammad Mohsin1 mohsinzaman3@gmail.com, Shahzad, Mirza Imran1, Jilani, Aeman1, Yousaf, Areeba1, Bashir, Ansah1, Riaz, Saher1, Rivera, Gildardo2
Publikováno v:
Advancements in Life Sciences. Aug2024, Vol. 11 Issue 3, p585-592. 8p.
Publikováno v:
Scopus-Elsevier
Expansion in telecommunications services, such as triple play and unified communications, introduces complexity that adversely affects service and network provisioning, especially in terms of provisioning times and the risk of delivery (failure) of n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::5825fbd60d6e8239692d4f2de23f4c72
https://hdl.handle.net/10453/19324
https://hdl.handle.net/10453/19324
Autor:
Tameris M; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa., Mearns H; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa., Penn-Nicholson A; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa., Gregg Y; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa., Bilek N; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa., Mabwe S; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa., Geldenhuys H; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa., Shenje J; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa., Luabeya AKK; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa., Murillo I; Biofabri, Pontevedra, Spain., Doce J; Biofabri, Pontevedra, Spain., Aguilo N; Department of Microbiology, Faculty of Medicine, University of Zaragoza, Zaragoza, Spain; CIBERES and Research Network on Respiratory Diseases, Spanish Ministry of Health and Instituto de Salud Carlos III, Madrid, Spain., Marinova D; Department of Microbiology, Faculty of Medicine, University of Zaragoza, Zaragoza, Spain; CIBERES and Research Network on Respiratory Diseases, Spanish Ministry of Health and Instituto de Salud Carlos III, Madrid, Spain., Puentes E; Biofabri, Pontevedra, Spain., Rodríguez E; Biofabri, Pontevedra, Spain., Gonzalo-Asensio J; Department of Microbiology, Faculty of Medicine, University of Zaragoza, Zaragoza, Spain; CIBERES and Research Network on Respiratory Diseases, Spanish Ministry of Health and Instituto de Salud Carlos III, Madrid, Spain., Fritzell B; Tuberculosis Vaccine Initiative, Lelystad, Netherlands., Thole J; Tuberculosis Vaccine Initiative, Lelystad, Netherlands., Martin C; Department of Microbiology, Faculty of Medicine, University of Zaragoza, Zaragoza, Spain; CIBERES and Research Network on Respiratory Diseases, Spanish Ministry of Health and Instituto de Salud Carlos III, Madrid, Spain; Servicio de Microbiología, Hospital Miguel Servet, ISS Aragon, Zaragoza, Spain., Scriba TJ; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa., Hatherill M; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa. Electronic address: mark.hatherill@uct.ac.za.
Publikováno v:
The Lancet. Respiratory medicine [Lancet Respir Med] 2019 Sep; Vol. 7 (9), pp. 757-770. Date of Electronic Publication: 2019 Aug 12.
Autor:
Horsnell, W. G. C., Vira, A., Kirstein, F., Mearns, H., Hoving, J. C., Cutler, A. J., Dewals, B., Myburgh, E., Kimberg, M., Arendse, B., White, N., Lopata, A., Burger, P. E., Brombacher, F.
Publikováno v:
Mucosal Immunology (1933-0219); Jan2011, Vol. 4 Issue 1, p83-92, 10p, 6 Graphs
Autor:
Moguche AO; Center for Infectious Disease Research (CIDR), Seattle, WA 98109, USA; Department of Immunology, University of Washington School of Medicine, Seattle, WA 98195, USA., Musvosvi M; South African Tuberculosis Vaccine Initiative (SATVI), University of Cape Town, Cape Town 7925, South Africa; Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town 7925, South Africa; Division of Immunology, Department of Pathology, University of Cape Town, Cape Town 7925, South Africa., Penn-Nicholson A; South African Tuberculosis Vaccine Initiative (SATVI), University of Cape Town, Cape Town 7925, South Africa; Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town 7925, South Africa; Division of Immunology, Department of Pathology, University of Cape Town, Cape Town 7925, South Africa., Plumlee CR; Center for Infectious Disease Research (CIDR), Seattle, WA 98109, USA., Mearns H; South African Tuberculosis Vaccine Initiative (SATVI), University of Cape Town, Cape Town 7925, South Africa; Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town 7925, South Africa; Division of Immunology, Department of Pathology, University of Cape Town, Cape Town 7925, South Africa., Geldenhuys H; South African Tuberculosis Vaccine Initiative (SATVI), University of Cape Town, Cape Town 7925, South Africa; Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town 7925, South Africa; Division of Immunology, Department of Pathology, University of Cape Town, Cape Town 7925, South Africa., Smit E; South African Tuberculosis Vaccine Initiative (SATVI), University of Cape Town, Cape Town 7925, South Africa; Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town 7925, South Africa; Division of Immunology, Department of Pathology, University of Cape Town, Cape Town 7925, South Africa., Abrahams D; South African Tuberculosis Vaccine Initiative (SATVI), University of Cape Town, Cape Town 7925, South Africa; Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town 7925, South Africa; Division of Immunology, Department of Pathology, University of Cape Town, Cape Town 7925, South Africa., Rozot V; South African Tuberculosis Vaccine Initiative (SATVI), University of Cape Town, Cape Town 7925, South Africa; Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town 7925, South Africa; Division of Immunology, Department of Pathology, University of Cape Town, Cape Town 7925, South Africa., Dintwe O; South African Tuberculosis Vaccine Initiative (SATVI), University of Cape Town, Cape Town 7925, South Africa; Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town 7925, South Africa; Division of Immunology, Department of Pathology, University of Cape Town, Cape Town 7925, South Africa., Hoff ST; Statens Serum Institut (SSI), 2300 Copenhagen, Denmark., Kromann I; Statens Serum Institut (SSI), 2300 Copenhagen, Denmark., Ruhwald M; Statens Serum Institut (SSI), 2300 Copenhagen, Denmark., Bang P; Statens Serum Institut (SSI), 2300 Copenhagen, Denmark., Larson RP; Center for Infectious Disease Research (CIDR), Seattle, WA 98109, USA., Shafiani S; Center for Infectious Disease Research (CIDR), Seattle, WA 98109, USA., Ma S; Center for Infectious Disease Research (CIDR), Seattle, WA 98109, USA., Sherman DR; Center for Infectious Disease Research (CIDR), Seattle, WA 98109, USA., Sette A; Department of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla 92037, USA., Lindestam Arlehamn CS; Department of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla 92037, USA., McKinney DM; Department of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla 92037, USA., Maecker H; Institute for Immunity, Transplantation, and Infection, Stanford University School of Medicine, Stanford, CA 94305, USA., Hanekom WA; South African Tuberculosis Vaccine Initiative (SATVI), University of Cape Town, Cape Town 7925, South Africa; Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town 7925, South Africa; Division of Immunology, Department of Pathology, University of Cape Town, Cape Town 7925, South Africa., Hatherill M; South African Tuberculosis Vaccine Initiative (SATVI), University of Cape Town, Cape Town 7925, South Africa; Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town 7925, South Africa; Division of Immunology, Department of Pathology, University of Cape Town, Cape Town 7925, South Africa., Andersen P; Statens Serum Institut (SSI), 2300 Copenhagen, Denmark., Scriba TJ; South African Tuberculosis Vaccine Initiative (SATVI), University of Cape Town, Cape Town 7925, South Africa; Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town 7925, South Africa; Division of Immunology, Department of Pathology, University of Cape Town, Cape Town 7925, South Africa. Electronic address: thomas.scriba@uct.ac.za., Urdahl KB; Center for Infectious Disease Research (CIDR), Seattle, WA 98109, USA; Department of Immunology, University of Washington School of Medicine, Seattle, WA 98195, USA. Electronic address: kevin.urdahl@cidresearch.org.
Publikováno v:
Cell host & microbe [Cell Host Microbe] 2017 Jun 14; Vol. 21 (6), pp. 695-706.e5.
Autor:
Robinson MJ; Malaghan Institute of Medical Research, Wellington 6242, New Zealand.; Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA 94143.; Sandler Asthma Basic Research Center, University of California, San Francisco, San Francisco, CA 94143., Prout M; Malaghan Institute of Medical Research, Wellington 6242, New Zealand., Mearns H; Malaghan Institute of Medical Research, Wellington 6242, New Zealand., Kyle R; Malaghan Institute of Medical Research, Wellington 6242, New Zealand., Camberis M; Malaghan Institute of Medical Research, Wellington 6242, New Zealand., Forbes-Blom EE; Malaghan Institute of Medical Research, Wellington 6242, New Zealand., Paul WE; Laboratories of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892; and., Allen CD; Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA 94143.; Sandler Asthma Basic Research Center, University of California, San Francisco, San Francisco, CA 94143.; Department of Anatomy, University of California, San Francisco, San Francisco, CA 94143., Le Gros G; Malaghan Institute of Medical Research, Wellington 6242, New Zealand; glegros@malaghan.org.nz.
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2017 Mar 01; Vol. 198 (5), pp. 1815-1822. Date of Electronic Publication: 2017 Jan 23.